BLUE News Alert Bluebird Bio Inc (BLUE) 88.76 12/25/2014 03:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bluebird Bio Inc (BLUE) 88.76 $BLUE

INVESTOR ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into bluebird bio, Inc. Regarding Possible Breaches of Fiduciary Duty
Business Wire - Tue Dec 23, 12:41PM CST
Levi & Korsinsky, LLP is investigating bluebird bio, Inc. (Nasdaq: BLUE) in connection with possible claims of breaches of fiduciary duty by the board of directors of the Company.
BLUE: 88.76 (+3.23)

3 Clinical Stage Biotech Stocks That Should Be on Your Watchlist in 2015
Motley Fool Staff - Motley Fool - Tue Dec 23, 6:07AM CST
Source: Celgene Corp Biotech stocks are notorious for their stratospheric gains and subterranean losses, especially clinical stage biotech stocks that develop promising, yet unproven, next-generation drugs. Those emerging biotech stocks may offer...
BLUE: 88.76 (+3.23), GSK: 42.85 (+0.11), BMY: 59.15 (-0.01), NVS: 93.91 (+0.66), CELG: 109.60 (+3.48), FPRX: 26.12 (+0.07), EXEL: 1.29 (-0.01)

Cramer's Mad Money - Look At Red Hat Go (12/19/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Dec 21, 4:26AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday December 19. CEO Interview, James Whitehurst, Red Hat (NYSE: RHT ) "Look at Red Hat ( RHT ) run." The stock dominates Open Source software for...
BLUE: 88.76 (+3.23), GPRO: 66.41 (+4.87), AVP: 9.22 (-0.07), SYNA: 69.57 (+0.11), NKE: 96.29 (+0.32), SKX: 55.48 (-0.28), DECK: 90.95 (-1.01), DIS: 94.42 (-0.27), CSIQ: 22.82 (+0.21), PAYX: 47.06 (-0.31), RDNT: 9.41 (-0.08), KITE: 51.96 (+0.45), RHT: 70.92 (+0.47), HAWK: 38.75 (+0.01), JUNO: 39.99 (+2.71), PAY: 37.55 (-0.83), WAG: 76.67 (+0.16)

The Winners for Best and Worst Biotech CEOs of 2014 Are...
at The Street - Thu Dec 18, 9:01AM CST
Congrats to David Schenkhein of Agios and Nick Leschly of Bluebird Bio for snagging 'Best' honors, while the ignominious (dis)honor of 'Worst' goes to Martin Shkreli, formerly of Retrophin.
BLUE: 88.76 (+3.23), RTRX: 12.92 (+0.19), AGIO: 109.67 (+2.45)

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses
at The Street - Thu Dec 18, 8:35AM CST
Gilead, Sangamo and Bluebird were great calls, Alexion and Vertex not so much.
BLUE: 88.76 (+3.23), VRTX: 115.15 (+1.40), GILD: 91.29 (+1.84), SRPT: 13.88 (+0.47), MRK: 57.46 (+0.25), SGMO: 14.20 (+0.14)

Juno Therapeutics: Saving The Best Biotech IPO For Last In 2014
Chris Katje - at Seeking Alpha - Wed Dec 17, 10:13AM CST

BLUE: 88.76 (+3.23), KITE: 51.96 (+0.45), JUNO: 39.99 (+2.71)

2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
at The Street - Wed Dec 17, 8:20AM CST
To prep investors for 2015, a list of clinical trial read-outs and FDA events expected to have a significant impact on stock prices in the first half of next year.
BLUE: 88.76 (+3.23), BIIB: 340.89 (+5.13), VRTX: 115.15 (+1.40), NBIX: 21.33 (+0.09), GILD: 91.29 (+1.84), ARWR: 6.35 (+0.07), SRPT: 13.88 (+0.47), MRK: 57.46 (+0.25), CTIC: 2.36 (+0.05), CEMP: 20.66 (+0.78), BMY: 59.15 (-0.01)

'Mad Money' Lightning Round: Enbridge Energy Partners Is a Great Stock
at The Street - Wed Dec 17, 5:00AM CST
Cramer says to wait on buying Chevron and Bluebird Bio until their shares are lower and stay away from EV Energy Partners.
BLUE: 88.76 (+3.23), TTWO: 28.60 (+0.18), ATVI: 20.35 (+0.12), SAIC: 50.99 (-0.27), EVEP: 21.87 (-0.94), ONVO: 6.84 (+0.03), TRN: 28.45 (+0.07), CVX: 113.47 (-0.48), EEP: 38.84 (+0.11)

Cramer's Lightning Round - Chevron Is Worth The Wait (12/16/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Dec 17, 4:03AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday December 16. Bullish Calls: Chevron (NYSE: CVX ): "CVX has a nice yield and it is good. You are going to have to wait till around $95 with a...
BLUE: 88.76 (+3.23), ATVI: 20.35 (+0.12), SAIC: 50.99 (-0.27), EVEP: 21.87 (-0.94), ONVO: 6.84 (+0.03), TRN: 28.45 (+0.07), CVX: 113.47 (-0.48), EEP: 38.84 (+0.11)

Jim Cramer's 'Mad Money' Recap: Goldilocks vs. 3 Bears, Where Nothing Is Just Right
at The Street - Tue Dec 16, 7:10PM CST
The bears may have won the day but there's still hope, Cramer says.
BLUE: 88.76 (+3.23), D: 78.38 (+1.48), RH: 96.97 (-0.16), COLM: 44.76 (-0.62), EEP: 38.84 (+0.11), TTWO: 28.60 (+0.18), ATVI: 20.35 (+0.12), PBR: 7.60 (-0.11), SAIC: 50.99 (-0.27), EVEP: 21.87 (-0.94), ONVO: 6.84 (+0.03), TRN: 28.45 (+0.07), CVX: 113.47 (-0.48)

Twitter's Favorite Biotech and Pharma Stocks
Brian Orelli, The Motley Fool - Motley Fool - Tue Dec 16, 8:21AM CST
Mark Schoenebaum, the biotech and pharmaceutical analyst at Evercore ISI, asked the Twittersphere for their favorite drug stocks going into next year. What's your favorite stock for 2015 in biotech or Pharma? — Mark Schoenebaum...
BLUE: 88.76 (+3.23), BMRN: 88.18 (+0.89), TGTX: 16.03 (+0.33), BMY: 59.15 (-0.01), MACK: 10.91 (+0.36), FMI: 23.99 (-0.10), RNA: 18.76 (+0.10), GWPH: 68.08 (+1.82), SRPT: 13.88 (+0.47), MRK: 57.46 (+0.25), NLNK: 39.08 (+1.36), ICPT: 151.49 (+5.85), THLD: 2.93 (+0.01), CEMP: 20.66 (+0.78), NVS: 93.91 (+0.66)

bluebird (BLUE) is in Overbought Territory: What's Next?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 65

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 10

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 115

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 96

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading

Top 5 Most Recently Viewed Articles

Antonio Filosa Takes the Helm as CEO of Stellantis N.V.

Updated Category News Views 335

Antonio Filosa Appointed as Stellantis N.V. Chief Executive Officer Stellantis N.V., a prominent player in the global automotive arena, has officially announced the appointment of Antonio Filosa as its new Chief Executive Officer. Filosa, who has amassed over 25 years of experience within the automotive sector, currently holds the position of Chief Operating Officer for...

Continue Reading
Understanding the Edwards Lifesciences Legal Landscape

Updated Category News Views 278

Understanding Recent Legal Issues for Investors In the world of investment, understanding legal implications can often feel overwhelming, especially when a company faces a class action lawsuit. Edwards Lifesciences Corporation, a name recognized for its innovative heart valve technologies, currently finds itself embroiled in legal battles that could shape its future and...

Continue Reading
Arrive Home and FormFree Join Forces to Enhance Homeownership Access

Updated Category News Views 155

Arrive Home Partners with FormFree for Innovative Solutions The innovative collaboration between Arrive Home and FormFree aims to transform the landscape of homeownership for many borrowers facing challenges due to limited credit histories. This partnership is particularly significant as it opens doors for those who have previously been overlooked by traditional credit...

Continue Reading
Verizon's $20 Billion Acquisition: A Strategic Expansion Ahead

Updated Category News Views 76

Verizon Announces Major Acquisition of Frontier Communications Verizon has recently made headlines by announcing a significant acquisition deal with Frontier Communications. This all-cash transaction, valued at $20 billion, underscores Verizon's dedication to substantially expanding its fiber network. Details of the Acquisition According to the proposed terms, Verizon...

Continue Reading
MoxiWorks Enhances Innovation Timeline with New Leadership and Funding

Updated Category News Views 174

MoxiWorks Enhances Innovation Timeline with New Leadership and Funding Funding from private equity and brokerage partners, along with new leadership, is set to transform MoxiWorks, a leading provider of sales and marketing software in the real estate sector. With substantial capital secured from its ownership group, which includes Vector Capital, Howard Hanna Real Estate...

Continue Reading